SLR Investment Q3 investment income falls on smaller portfolio
Reuters2026/11/03 21:13
Overview
US specialty finance firm's Q3 net investment income per share was flat sequentially at $0.33
Q3 net investment income fell to $17.8 mln from $21.6 mln due to a smaller average income-producing portfolio
Company declared $0.31-per-share quarterly distribution and repurchased $10 mln of shares in October
Outlook
SLR Investment declared a quarterly distribution of $0.31 per share, payable Dec. 28
Company expects continued focus on specialty finance originations amid higher-for-longer interest rates
Company says it is well positioned to deploy over $850 mln in available capital
Result Drivers
PORTFOLIO SIZE - Co said lower gross and net investment income yr/yr was mainly due to a smaller average investment portfolio
SPECIALTY FINANCE ORIGINATIONS - 95% of $575 mln in new investments were in specialty finance, which co expects to continue
PORTFOLIO QUALITY - Co said watchlist loans remain below historical average and portfolio credit quality remains stable
Company press release: ID:nGNX2LbPqY
Key Details
Metric |
Beat/Miss |
Actual |
Consensus Estimate |
Q3 Investment Originations |
|
$575.10 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", 3 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the closed end funds peer group is "buy"
Wall Street's median 12-month price target for SLR Investment Corp is $14.00, about 18.5% above its November 2 closing price of $11.81
The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 9 three months ago
Reuters Recommended Reads
Nov 2 - New Mountain Finance Q3 adjusted net investment income falls YoY
Nov 2 - Great Elm Capital Q3 net investment income and NAV fall
Nov 3 - Apollo assets reach $1.07 trillion on alternative investment demand
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny
CoreWeave will release its third-quarter financial report. Whether it can demonstrate that its rapid revenue growth is sufficient to cover the rising financing costs and construction expenditures will directly determine the direction of market confidence.
